IRIS
REBUZZI, SARA ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.876
NA - Nord America 479
AS - Asia 470
Continente sconosciuto - Info sul continente non disponibili 71
SA - Sud America 44
AF - Africa 3
Totale 2.943
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.799
US - Stati Uniti d'America 458
SG - Singapore 140
BD - Bangladesh 94
CN - Cina 90
VN - Vietnam 90
BR - Brasile 29
FI - Finlandia 23
FR - Francia 21
HK - Hong Kong 15
GB - Regno Unito 10
CA - Canada 8
IN - India 8
MX - Messico 7
AR - Argentina 6
DE - Germania 6
ID - Indonesia 5
JP - Giappone 5
TH - Thailandia 4
CO - Colombia 3
PH - Filippine 3
UZ - Uzbekistan 3
AL - Albania 2
AT - Austria 2
CL - Cile 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IE - Irlanda 2
IR - Iran 2
RS - Serbia 2
SA - Arabia Saudita 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
GT - Guatemala 1
HR - Croazia 1
IQ - Iraq 1
JO - Giordania 1
KR - Corea 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
PT - Portogallo 1
RO - Romania 1
SY - Repubblica araba siriana 1
TR - Turchia 1
TW - Taiwan 1
UA - Ucraina 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 2.872
Salva come PNG Salva come JPEG
Città #
Genoa 1.204
Vado Ligure 218
Rapallo 185
Genova 106
Ashburn 86
Singapore 65
San Jose 55
Ho Chi Minh City 32
Council Bluffs 31
Helsinki 21
Lauterbourg 21
Beijing 20
Milan 19
Rome 19
Los Angeles 18
Santa Clara 18
Hanoi 15
Hong Kong 13
New York 12
Chicago 11
St Louis 10
Boardman 7
Buffalo 7
Hamilton 6
Orem 6
Bordighera 5
Carrabelle 5
Da Nang 5
Dallas 5
Houston 5
Atlanta 4
Haiphong 4
Hải Dương 4
Las Vegas 4
Phoenix 4
São Paulo 4
The Bronx 4
Turin 4
Bari 3
Cardiff 3
Frankfurt am Main 3
Naples 3
Philadelphia 3
Thái Nguyên 3
Tokyo 3
Verona 3
Washington 3
Belgrade 2
Biên Hòa 2
Brooklyn 2
Cary 2
City of London 2
Claymont 2
Dublin 2
East Brunswick 2
Federal Way 2
Flint 2
Fredericksburg 2
Fresno 2
Guangzhou 2
Kansas City 2
Lappeenranta 2
London 2
Louisville 2
Lyndhurst 2
Mexico City 2
Newark 2
North Charleston 2
Nuremberg 2
Parker 2
Poplar 2
San Juan 2
Tashkent 2
Toronto 2
Vienna 2
Abilene 1
Adelfia 1
Albany 1
Alexandria 1
Amman 1
Amqui 1
Ancona 1
Atoka 1
Aversa 1
Bamberg 1
Bandung 1
Baton Rouge 1
Belford Roxo 1
Bellflower 1
Bengaluru 1
Bilaspur 1
Blanchard 1
Bloomington 1
Blue Island 1
Bologna 1
Bolzano 1
Brampton 1
Brescia 1
Brugherio 1
Bryan 1
Totale 2.370
Salva come PNG Salva come JPEG
Nome #
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome? 235
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 181
THE PROGNOSTIC ROLE OF THE IMMUNE TUMOR MICROENVIRONMENT IN METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH IMMUNOTHERAPY (Meet-URO 18 I-TME study) 159
Hyperthyroidism in non-seminomatous testicular germ cell tumors: two case reports and literature review 134
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study) 125
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib 123
Feasibility of multiple immunoexpression assay for immune tumor micrornvironment (I-TME) on matched metastatic and primary renal cell carcinoma (RCC) for patient prognostication and predictiveness to immunotherapy (preliminary analyses of the Meet URO 18 study). 122
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study) 110
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review 109
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study 107
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab 107
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223 105
Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study 105
Beyond first-line immunotherapy: Potential therapeutic strategies based on different pattern progressions: Oligo and systemic progression 99
Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives 96
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study 94
Fusion 3D gross sampling method to overcome heterogeneity in clear cell renal cell carcinoma (ccRCC) and grading angiogenic versus immune signatures. 93
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study 92
Systemic therapy for pre-treated malignant mesothelioma: A systematic review, meta-analysis and network meta-analysis of randomised controlled trials 86
Neuroendocrine differentiation of prostate cancer is not systematically associated with increased 18f-fdg uptake 81
Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case report 80
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 77
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis 75
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9) 72
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 71
Prognostic models for patients with metastatic urothelial carcinoma: why use them? 62
The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis 61
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study 57
Large Italian Multicenter Study on Prognostic Value of Baselines Variables in mCRPC Patients Treated with 223RaCl2: Ten Years of Clinical Experience 25
Totale 2.943
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.402
article - articoli 11.104
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.506
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202280 1 1 3 1 0 3 1 11 13 12 11 23
2022/2023216 13 15 7 26 23 19 9 30 31 6 37 0
2023/2024168 7 17 3 23 14 31 11 7 3 16 7 29
2024/2025595 53 42 15 30 64 56 44 115 32 24 64 56
2025/20261.629 149 179 265 120 155 64 170 53 143 121 101 109
2026/2027212 212 0 0 0 0 0 0 0 0 0 0 0
Totale 2.943